These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 16000338)

  • 1. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
    Silva MF; Faria P; Regateiro FS; Forjaz V; Januário C; Freire A; Castelo-Branco M
    Brain; 2005 Oct; 128(Pt 10):2260-71. PubMed ID: 16000338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test.
    Moura AL; Teixeira RA; Oiwa NN; Costa MF; Feitosa-Santana C; Callegaro D; Hamer RD; Ventura DF
    Vis Neurosci; 2008; 25(3):463-8. PubMed ID: 18598419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease.
    Haug BA; Trenkwalder C; Arden GB; Oertel WH; Paulus W
    Mov Disord; 1994 Sep; 9(5):563-70. PubMed ID: 7990852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease (Silva MF et al. Brain 2005; 128: 2260-2271).
    Gaynes BI
    Brain; 2006 Dec; 129(Pt 12):e61; aauthor reply e62. PubMed ID: 17132640
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential aging of chromatic and achromatic visual pathways: behavior and electrophysiology.
    Page JW; Crognale MA
    Vision Res; 2005 May; 45(11):1481-9. PubMed ID: 15743617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise.
    Flanagan P; Zele AJ
    Ophthalmic Physiol Opt; 2004 May; 24(3):225-33. PubMed ID: 15130171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motion integration deficits are independent of magnocellular impairment in Parkinson's disease.
    Castelo-Branco M; Mendes M; Silva F; Massano J; Januário G; Januário C; Freire A
    Neuropsychologia; 2009 Jan; 47(2):314-20. PubMed ID: 18822307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatic and achromatic visual evoked potentials in Parkinson's disease.
    Büttner T; Kuhn W; Müller T; Heinze T; Pühl C; Przuntek H
    Electroencephalogr Clin Neurophysiol; 1996 Sep; 100(5):443-7. PubMed ID: 8893662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor visual discrimination and visual hallucinations in Parkinson's disease.
    Diederich NJ; Goetz CG; Raman R; Pappert EJ; Leurgans S; Piery V
    Clin Neuropharmacol; 1998; 21(5):289-95. PubMed ID: 9789709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinotopic distribution of chromatic responses in human primary visual cortex.
    Vanni S; Henriksson L; Viikari M; James AC
    Eur J Neurosci; 2006 Sep; 24(6):1821-31. PubMed ID: 17004945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatio-temporal selectivity of loss of colour and luminance contrast sensitivity with multiple sclerosis and optic neuritis.
    Flanagan P; Markulev C
    Ophthalmic Physiol Opt; 2005 Jan; 25(1):57-65. PubMed ID: 15649184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal function in best macular dystrophy: relationship between electrophysiological, psychophysical, and structural measures of damage.
    Maia-Lopes S; Silva ED; Reis A; Silva MF; Mateus C; Castelo-Branco M
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5553-60. PubMed ID: 18775865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual dysfunction in Parkinson's disease.
    Rodnitzky RL
    Clin Neurosci; 1998; 5(2):102-6. PubMed ID: 10785835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colour contrast sensitivity in patients with age-related Bruch's membrane changes.
    Holz FG; Gross-Jendroska M; Eckstein A; Hogg CR; Arden GB; Bird AC
    Ger J Ophthalmol; 1995 Nov; 4(6):336-41. PubMed ID: 8751098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in pattern electroretinograms to equiluminant red-green and blue-yellow gratings in patients with early Parkinson's disease.
    Sartucci F; Orlandi G; Lucetti C; Bonuccelli U; Murri L; Orsini C; Porciatti V
    J Clin Neurophysiol; 2003; 20(5):375-81. PubMed ID: 14701999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplitude of the transient visual evoked potential (tVEP) as a function of achromatic and chromatic contrast: contribution of different visual pathways.
    Souza GS; Gomes BD; Lacerda EM; Saito CA; da Silva Filho M; Silveira LC
    Vis Neurosci; 2008; 25(3):317-25. PubMed ID: 18321403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatic tuning of contour-shape mechanisms revealed through the shape-frequency and shape-amplitude after-effects.
    Gheorghiu E; Kingdom FA
    Vision Res; 2007 Jun; 47(14):1935-49. PubMed ID: 17499333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal integration of the chromatic channels in peripheral vision.
    Masuda O; Uchikawa K
    Vision Res; 2009 Mar; 49(6):622-36. PubMed ID: 19948110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal and dichromatic color discrimination measured with transient visual evoked potential.
    Gomes BD; Souza GS; Rodrigues AR; Saito CA; Silveira LC; da Silva Filho M
    Vis Neurosci; 2006; 23(3-4):617-27. PubMed ID: 16962005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orientation selectivity in luminance and color vision assessed using 2-d band-pass filtered spatial noise.
    Beaudot WH; Mullen KT
    Vision Res; 2005 Mar; 45(6):687-96. PubMed ID: 15639495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.